Dominic Reynolds

Dominic Reynolds

Company: Remix Therapeutics

Job title: Senior Vice President & Head of Drug Discovery


Utilizing Screening Methodologies to Study Physiological Responses 11:00 am

Using RNA-sequencing to determine the specific effects elicited by the small molecules when interacting with the target RNA Identifying the correct confirmations with the use of cell screening for higher predictabilit How to use cell-free RNA-binding assays to identify small molecules that bind RNA and elicit a desired on-target response in cellular conditionsRead more

day: Day 1 Track A AM

Panel Discussion: Overcoming Key Challenges to Improve Drug Design & Discovery for Novel Approaches 3:30 pm

Navigating the current landscape of small molecules targeting RNA How can the unlimited potential to target RNA with small molecules be explored and exploited to develop novel approaches? What are the lessons from other modalities that can be leveraged to develop small molecules that target RNA? What needs to happen for this modality to become…Read more

day: Day 1 PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.